Any current/future new fundraising through debt or equity?

The company currently has a very healthy cash balance as of June 30, 2024. There are no external borrowings outstanding. The company is being very prudent in its CAPEX investments, with envisaged expenses around Rs.100 crore. There is no mention of any plans for new fundraising through debt or equity in the provided transcript. The focus appears to be on improving capital efficiencies and managing working and fixed capital effectively rather than raising new funds.

Any current/future capex/capital investment/strategic investment?

The company is very prudent in CAPEX investment, envisaging expenses around Rs.100 crore. Investments are being made in automation to improve manufacturing efficiency and timely delivery. Digital investments are continuing, focusing on customer connectivity and leveraging digital tools for better planning and forecasting. Plans to build an integrated R&D facility in Bangalore, combining two R&D centers, expected to be ready in two years. Strategic focus on partnerships and collaborations with global and domestic companies to refresh and strengthen the product portfolio. Investment in expanding

Future growth expectations in sales/revenue/volumes?

Domestic business is expected to improve with positive monsoon sentiments and new MSP, leading to significant volume growth. Export volumes showed a 19% growth in the quarter; continuation depends on molecule-specific market dynamics. Crop care domestic business grew 13% in volume; herbicides and recent product launches like Clasto are key growth drivers. Crop nutrition segment grew around 31%, considered a strong pillar for long-term growth with better margins. Cotton packets sales are expected to grow significantly, especially in North cotton. Supply constraints in seeds like hybrid maize an

Future growth expectations in earnings/operating earnings/profits/EPS?

Domestic business expected to improve as monsoon progresses, with positive sentiment and careful inventory planning leading to volume growth. Export volumes have seen a 19% growth but pricing remains uncertain; profitability under pressure due to price declines and high inventory. Seeds business will focus on profitability with calibrated placements; highest-ever cotton packet sales expected in FY25. Crop nutrition shows strong growth with higher margins than crop protection; new product launches to support growth. Digital investments and automation targeting internal efficiencies, customer co

Rallis India LtdQ1 FY25Fertilizers & Agrochemicals

Rallis India Ltd Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹200P/E: 17.1Market Cap: ₹3.9K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 2

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

Domestic business is expected to improve with positive monsoon sentiments and new MSP, leading to significant volume growth.
Export volumes showed a 19% growth in the quarter; continuation depends on molecule-specific market dynamics.
Crop care domestic business grew 13% in volume; herbicides and recent product launches like Clasto are key growth drivers.
Crop nutrition segment grew around 31%, considered a strong pillar for long-term growth with better margins.
Cotton packets sales are expected to grow significantly, especially in North cotton.
Supply constraints in seeds like hybrid maize and paddy have impacted growth; efforts ongoing to resolve these.
Focus on portfolio optimization, including new product launches and phasing out low-margin products, aims to enhance growth.
Collaborative partnerships for product development and supply chain certainty are part of growth strategy.
Overall, the company is confident and optimistic about medium-to-long-term growth prospects.

Margin guidance

Category 2

Domestic business expected to improve as monsoon progresses, with positive sentiment and careful inventory planning leading to volume growth.
Export volumes have seen a 19% growth but pricing remains uncertain; profitability under pressure due to price declines and high inventory.
Seeds business will focus on profitability with calibrated placements; highest-ever cotton packet sales expected in FY25.
Crop nutrition shows strong growth with higher margins than crop protection; new product launches to support growth.
Digital investments and automation targeting internal efficiencies, customer connectivity, and supply chain improvements, aiming for better return on capital.
Margin improvement expected via portfolio churn, focusing on differentiated products, phasing out unprofitable ones.
EBITDA for Q1 FY25 was Rs.96 crore vs Rs.110 crore last year; management aims to restore margins as market conditions improve.
Medium-to-long-term outlook is positive, driven by a combination of domestic growth, export recovery, and operational efficiencies.
FY26-27 growth levers include domestic and export business improvements and potentially manufacturing efficiencies.

See what Rallis India Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

The company currently has a very healthy cash balance as of June 30, 2024.
There are no external borrowings outstanding.
The company is being very prudent in its CAPEX investments, with envisaged expenses around Rs.100 crore.
There is no mention of any plans for new fundraising through debt or equity in the provided transcript.
The focus appears to be on improving capital efficiencies and managing working and fixed capital effectively rather than raising new funds.

Order book

The transcript provided in the document does not explicitly mention specific details about the current or expected order book or pending orders for Rallis India Limited. However, from the discussion, some relevant insights can be drawn: - There was an inventory impact in Q1 due to high rabi inventory, which was corrected during the quarter. - The company is cautious with inventory placements and expects better liquidation trends. - Domestic crop care shows positive volume growth with improved monsoon sentiment aiding demand. - Export business volumes are growing (~19% volume growth reported), but pricing remains challenging due to oversupply from China. - The company is focusing on portfolio optimization, territorial rationalization, and improving customer connectivity to sustain growth. - They launched new products in crop care and seeds to drive business resilience. - No direct quantitative data on order book or pending orders was shared in the call. If detailed current or expected order book figures are needed, they may be available in other company disclosures or reports.

See what Rallis India Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

The company is very prudent in CAPEX investment, envisaging expenses around Rs.100 crore.
Investments are being made in automation to improve manufacturing efficiency and timely delivery.
Digital investments are continuing, focusing on customer connectivity and leveraging digital tools for better planning and forecasting.
Plans to build an integrated R&D facility in Bangalore, combining two R&D centers, expected to be ready in two years.
Strategic focus on partnerships and collaborations with global and domestic companies to refresh and strengthen the product portfolio.
Investment in expanding formulation alliances in the contract manufacturing business to improve capacity utilization at the Dahej chemical zone facility.
Continued focus on evolving portfolio with differentiated products and phasing out low-margin or less profitable ones.

Track Rallis India Ltd — get its next earnings analysis in your feed

How does Rallis India Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

ThisRallis India Ltd

Rev 3Mar 2

See where Rallis India Ltd sits in Fertilizers & AgrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Rallis India Ltd rank in Fertilizers & Agrochemicals?

Compare Rallis India Ltd against every Fertilizers & Agrochemicals company (Q1 FY25) on revenue, margins and earnings-call signals.

View Fertilizers & Agrochemicals leaderboard →

What Rallis India Ltd's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Advance Agrolife Ltd (Q4 FY26)
Q4 FY26 total revenue: ₹1,259.07 million, up 40% YoY (Page 24). Key concall takeaways from Advance Agrolife Ltd's Q4 FY26 earnings call — and how it ranks…
Advance Agrolife Ltd (Q1 FY27)
Q1 FY27 revenue from operations: ₹3,304 million, a 96% year-on-year (YoY) increase (Page 23, 25, 22). Key concall takeaways from Advance Agrolife Ltd's Q1 FY27…
Bhagiradha Chemicals & Industries Ltd (Q4 FY26)
158.1 crores . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
Bhagiradha Chemicals & Industries Ltd (Q1 FY27)
195.0 crore . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Coromandel International Ltd vs Fertilizers & Chemicals Travancore Ltd vs UPL

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →